SciLife Consulting

Active

Private limited companyfounded 2019active for 7 yearsWaterstraat 9A, 3071 Kortenberg, BelgiumKBO/BCE: BE 0732.585.174

Summary

SciLife Consulting has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €127,331 and a net result of €47,622. Equity is growing by about 13% per year across the filed financial years. Its solvency ranks better than 53% of 613 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

SciLife ConsultingActiveChecked score 95/100

Risk analysis Report Compare

Activity

Research and development on biotechnology

NACE 72101

1 site

Size

≈ €230,000turnover 2025, estimated

Staff: ≈ 0.1 FTE, estimated
Equity: €127,331
Profit: €47,622

Turnover estimated from the gross margin

Financial health

95 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Structure

2025 accounts 30 days early1 deed in the Belgian Official Gazette

Why 95lowers riskLiquidity: current ratio 2.32, cash €83,814Sector: Scientific research and development (NACE 72)Equity €127,331 (64.2% of total assets)Size: total assets €198,474Show the evidence

Checked score

Score 2025

95 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 61% of its sector peers (NACE 72, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 89+1

equity 64.2% of total assets

Liquidity 84+1

short-term debt 35.1% · cash 42.2%

Profitability 99-1

return on assets 24.0%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (935 companies, NACE 72, micro)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: 0.1%▲ +0.1 percentage points vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025highest value 05-2025: < 0.1%▼ -0.1 percentage points vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: 0.1%▲ +0.1 percentage points vs 03-2026 05-2026: < 0.1%▼ -0.1 percentage points vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €12,000 on 30-day terms is acceptable

Liquidity ample (current ratio 2.32, compared with 2.2 in 2024, above the usual 1.5; short-term debt: 35.1% and cash: 42.2% of total assets), and 35.8% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro): better than 56% on solvency, 73% on liquidity, 80% on profitability and 36% on growth.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskneutral

Liquidity: current ratio 2.32, cash €83,814

NBB · annual accounts

Sector: Scientific research and development (NACE 72)

KBO

Equity €127,331 (64.2% of total assets)

NBB · annual accounts

Size: total assets €198,474

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 31-03-2026, 30 days ahead of the deadline.

NBB · 6 filings

Deviation from the deadline

2025

30 days early

2024

30 days early

2023

30 days early

2022

1 day early

2021

30 days early

2020

30 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 25 days before the deadline; the sector median (NACE 72) for financial year 2024 is 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 31 March (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

30-09-2026 year end30-10-2026 today30-04-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

31-03-2026 Annual accounts filedfinancial year 2025 · micro…
31-03-2025 Annual accounts filedfinancial year 2024 · micro…
30-09-2024 Highest result from 2020 to 2025net €64,312 ▲38.3%

Key points

Positive: Always filed on timeaccounts within the deadline every year 6 years View
Positive: 6 profitable years in a rowprofit 2025: €47,622 6 years View
Total assets 20256 financial years filed €198,474 View

By topic

Financials

Financial year: 2025
Total assets: €198,474
Profit: €47,622
Solvency: 64.2%

Total assets▼ 9.4%

Net result

20202025

Go to Financials

Timeline

Events: 9
Since: 2021
Next accounts: by 30-04-2027

31-03-2024Annual accounts filed
29-04-2023Annual accounts filed
30-09-2022Weakest financial year

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company
Activity: Research and development on biotechnologyNACE 72101
Founded: 13-08-2019
Year ends: 30-09
Peppol: Reachable for e-invoices

Go to Company details

Key facts about SciLife Consulting

What is the company number of SciLife Consulting?: 0732.585.174. In Belgium the VAT number is the company number with BE in front: BE 0732.585.174.
Where is SciLife Consulting based?: The registered office is at Waterstraat 9A, 3071 Kortenberg.Company details
What does SciLife Consulting do?: According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of SciLife Consulting?: Private limited company (BV).
When was SciLife Consulting founded?: On 13-08-2019.
Is SciLife Consulting still active?: Yes, SciLife Consulting is an active enterprise in the KBO register.
What is the turnover of SciLife Consulting?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is SciLife Consulting profitable?: In financial year 2025, SciLife Consulting made a profit of €47,622.
Where can I find the annual accounts of SciLife Consulting?: SciLife Consulting filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SciLife Consulting due?: By 30-04-2027, for financial year 2026.Timeline